OPK Biotech developed and manufactured hemoglobin-based oxygen carriers (HBOCs) used to transport oxygen to the body's tissues. Oxyglobin was developed to treat all-cause anemia in dogs, and Hemopure was for human use. The veterinary product is approved in the US and EU, although currently not being promoted. Hemopure is approved for use in South Africa and Russia.